Selkova E.P., Grenkova T.A., Aleshkin V.А., Gudova N.V., . Lytkina I.N., Mikhailova E.V., Yashina A.Ya., Fedyakina I.T.
1G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare; 2V.I. Razumovsky Saratov State Medical University, Ministry of Health of Russia; 3D.I. Ivanovsky Institute of Virology, Ministry of Health of Russia, Honorary Academician N.F Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of Russia, Moscow
1. Gosudarstvennyiy doklad «O sostoyanii sanitarno-epidemiologicheskogo blagopoluchiya naseleniya v Rossiyskoy Federatsii v 2014 godu» [The state report «About a condition of sanitary and epidemiologic wellbeing of the population in the Russian Federation in 2014»]. http://rospotrebnadzor.ru/upload/iblock/22c/gd_2014_seb_dlya-sayta.pdf. (In Russ.). 2. Huckriede A., Bungener L., Stegmann T., Daemen T., Medema J., Palache A.M., Wilschut J. The virocome concept for influenza vaccines. Vaccine 2005; 23(Suppl. 1): S26–S38. 3. Kanra G., Marchisio P., Feiterna-Sperling C. Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children. Pediatr. Infect. Dis. J. 2004; 23(4): 300–306. 4. Bruijn I.A., Nauta J., Gerez L., Palache A.M. Virosomal influenza vaccine: a safe and effective influenza vaccine with high efficacy in elderly and subjects with low pre-vaccination titers. Virus Res. 2004; 103(1–2): 139–145. 5. Zverev V.V., Mihajlova N.A., Korovkin S.A., Mironov A.N., Mel’nikov S.Ja., Erofeeva M.K., Dyldina N.V., Nikonorov I.Ju., Maksakova V.L. [Development and deployment in practice of health care of the Russian Federation of the new domestic split virosomalny flu vaccine]. Lechashhij Vrach 2008; 9: 68–70. (In Russ.). 6. Kiselev O.I., Korovkin S.A., Mironov A.N., Mel’nikov S.Ja., Dyldina N.V., Erofeeva M.K., Sominina A.A., Vojcehovskaja E.M., Stukova M.A. [Results of clinical trial of a reaktogennost, safety and an immunogenicity of a vaccine of «Ultriks®» on the elderly contingent (of 60 years is also more senior)]. Еpidemiologiya i Vakcinoprofilaktika 2008; 4: 36–39. (In Russ.). 7. Korovkin S.A., Mironov A.N., Mel’nikov S.Ja., Mihajlova N.A., Kostinov M.P., Dyldina N.V., Zhirova S.N. [An assessment of a reaktogennost, safety and an immunogenicity of the virosomalny split inactivated influenzal vaccine of «Ultriks®» in the I phase of clinical trial]. Zhurnal Mikrobiologii, Epidemiologii i Immunologii 2009; 1: 26–31. (In Russ.). 8. Zverev V.V., Kiselev O.I., Korovkin S.A., Mironov A.N., Mel’nikov S.Ja., Mihajlova N.A., Kostinov M.P., Erofeeva M.K., Sominina A.A., Dyldina N.V., Zhirova S.N., Stukova M.A. [Clinical trial of the new inactivated influenzal vaccine of «Ultriks®»]. Zhurnal Mikrobiologii, Epidemiologii i Immunologii 2009; 2: 35–40. (In Russ.). 9. Nikonorov I., Maksakova V., Fel’dbljum I., Konshina O., Erofeeva M.[ A domestic preparation for prevention of flu of the last generation]. Vrach 2014; 3: 67–72. (In Russ.). 10. Metodyi opredeleniya kachestva immunobiologicheskih preparatov dlya profilaktiki grippa. Metodicheskie ukazaniya MU 3.3.2.1758-03. [Methods of determination of quality of immunobiological preparations for prevention of flu. HOWTO MU 3.3.2.1758-03]. Moscow, 2003. (In Russ.). 11. Concept Paper on the Revision of the CPMP/BWP Note for Guidance on Harmonization of Requirements for Influenza Vaccines (CPMP/BWP/214/96). London, 31 May, 2001/CPMP/EWP/1045/01.
For correspondence:
Grenkova Tatyana Arkadyevna, Cand. Med. Sci.; Leading Researcher, Laboratory for Diagnosis and Prevention of Infectious Diseases, G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare
Address: 10, Admiral Makarov, Moscow 125212
Telephone: +7(499) 747-64-73
E-mail: g4209761@bk.ru